Permisivna hiperkapnija-strategija tretmana mehanički ventilirane nedonoščadi
DOI:
https://doi.org/10.5457/ams.v47iSup%201.414Keywords:
ventilator, premature infant, hypercapniaAbstract
Advanced in perinatal care such as surfacant, antenatal steroids, and improved ventilatory suport have markedly reduced mortality rates of premature infants, allowing the survival of many critically ill infants. But, the improved survival of these vulbnerable newbrns has increased the number of infants at risk for various forms of respiratory morbidities including brnochopulmonry displasia and lear leaks. There are physiological rationale and experimantal data that sugest permissive hypercapnia may be well tolerated and result in reduced lung injury in mehanical ventilated premature newborns. Permissive hypercapnia or controlled ventilation is a strategy that minimize baro/volutrauma by allowing relativly high level of arterial CO2, provided that arterial pH does not fall bellow a preset minimal value. Gradual small elevations in pCO2 are relatively safe as long as the pH stops above 7.20. Thus, in permissive hypercapnia priority is given to the prevention or limitation of overventilation rather than maintenace of normal blood gases and alveolar ventilation. Mild to moderate alveolar hyoventilation and respiratory acidosis may be well tolerated and my lead to prevention of pulmoray volutrauma in premature infants. There is need for futher research testing to determine the appropriate clinical application of permisive hypercapnia, the optimal level of hypercapnic acidosis, without an increased risk of impaired neurodevelopment or other adverse efects.
Published
Issue
Section
License
Copyright transfer
The listed authors warrant that they are the authors and sole owners of the submitted manuscript. The authors also warrant that the work is original; that it has not been previously published in print or electronic format and is not under consideration by another publisher or electronic medium; that it has not been previously transferred, assigned, or otherwise encumbered; and that the authors have full power to grant such rights. With respect to the results of this work, the manuscript of this or substantially similar content will not be submitted to any other journal until the review process in the Acta Medica Salinianana has been officially completed (acceptance or rejection of the manuscript). The paper will not be withdrawn from the review process by the Acta Medica Saliniana Editorial Board until the review process is completed. The authors will comply with the requests of the Acta Medica Saliniana Editors and reviewers to improve the paper for publication. The eventual disagreements will be submitted in a written form; the authors are aware that the disagreement(s) with the Acta Medica Saliniana requests may result in the rejection of the manuscript. The authors hereby grant to the Acta Medica Saliniana the right to edit, revise, abridge, and condense the manuscript. If the manuscript is accepted for publication in the Acta Medica Saliniana, the authors hereby transfer the copyright of the paper to the Acta Medica Saliniana. The authors permit the Acta Medica Saliniana to allow third parties to copy any part of the journal without asking for permission, provided that the reference to the source is given. For papers with more than one author: All other co-authors agree to allow the corresponding author to make decisions regarding prepublication release of the information in the paper to the media, federal agencies, or both.
